Dynamics of matrix metalloproteinases when correcting immature hypertrophic scars with pulsed dye laser and fermencol phonophoresis

The article analyzes the role of matrix metalloproteinases (MMP) in the pathogenesis of immature hypertrophic scars. The revealed decrease in the MMP level in the patients’ initial state against the background of an increased content of TIMP1 indicates a disorder in the mechanisms of regulation of collagen formation in a hypertrophic scar, as a result of which its synthesis significantly predominates over decay, contributing to the formation of a fibrous process. The obtained results convincingly prove that reduced expression of MMP against the background of an increased TIMP1 level is an important pathogenetic mechanism providing excessive deposition of extracellular matrix components in pathological skin scarring. The use of a pulsed dye laser (PDL) in combination with Fermencol phonophoresis promotes an increase in the MMP content in the blood serum of patients with immature hypertrophic scars. The reliable dynamics of the studied biomarkers indicates an increase in the processes of catabolism of the extracellular matrix components and an increase in the regenerative potential of the skin defect, which determine the intensity of the clinical effect during the treatment of immature hypertrophic scars. The correlation analysis between the level of membrane metalloproteinases and the parameters of the Vancouver Scar Scale revealed a set of significant relationships that confirm the clinical and pathogenetic significance of these biochemical variables in the development of fibroplastic processes and also act as informative criteria for the effectiveness of the therapy.

[1]  T. Valiev,et al.  Results of Infantile Hemangioma Laser Therapy in Children with Persistent Residual Signs after Systemic Propranolol Therapy: Clinical Cases , 2021, Current Pediatrics.

[2]  A. Bachi,et al.  BMP-7, MMP-9, and TGF-β tissue remodeling proteins and their correlations with interleukins 6 and 10 in chronic rhinosinusitis , 2021, European Archives of Oto-Rhino-Laryngology.

[3]  G. Luo,et al.  Vascularity and Thickness Changes in Immature Hypertrophic Scars Treated With a Pulsed Dye Laser , 2020, Lasers in surgery and medicine.

[4]  K. Zeng,et al.  The Mechanism of miR-222 Targets Matrix Metalloproteinase 1 in Regulating Fibroblast Proliferation in Hypertrophic Scars , 2020, Aesthetic Plastic Surgery.

[5]  L. Adamyan,et al.  The role of matrix metalloproteinases in the pathogenesis of endometriosis(literature review) , 2020 .

[6]  Song-Tu Zhang,et al.  Effects of photoelectric therapy on proliferation and apoptosis of scar cells by regulating the expression of microRNA‐206 and its related mechanisms , 2019, International wound journal.

[7]  I. E. Smirnov,et al.  LASER SURGERY FOR SKIN VASCULAR TUMORS IN INFANTS , 2019, Russian Pediatric Journal.

[8]  Viktoriya Andreeva,et al.  Modern View on Classification of Cicatricial Skin Deformations , 2018, Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор).

[9]  E. Gershtein,et al.  MATRIX METALLOPROTEINESES AND THEIR TISSUE INHIBITORS IN PRIMARY BONE TUMOR PATIENTS: CLINICAL AND PATHOLOGIC CORRELATIONS , 2018, Molekulyarnaya Meditsina (Molecular medicine).

[10]  R. Khalil,et al.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease. , 2018, Advances in pharmacology.

[11]  Андрей Андреевич Морозов,et al.  Классификация, регуляция активности, генетический полиморфизм матриксных металлопротеиназ в норме и при патологии , 2017 .

[12]  P. Álvares,et al.  Immunohistochemical expression of TGF-β1 and MMP-9 in periapical lesions. , 2017, Brazilian oral research.

[13]  D. Scheffel,et al.  Proliferation, migration, and expression of oral‐mucosal‐healing‐related genes by oral fibroblasts receiving low‐level laser therapy after inflammatory cytokines challenge , 2016, Lasers in surgery and medicine.

[14]  A. Romanchuk,et al.  Matrix metalloproteinases: relationship with cytokines system, diagnostic and prognostic potential , 2016 .

[15]  E. Tredget,et al.  The molecular basis of hypertrophic scars , 2016, Burns & Trauma.

[16]  C. Jackson,et al.  Extracellular Matrix Reorganization During Wound Healing and Its Impact on Abnormal Scarring. , 2015, Advances in wound care.

[17]  V. Moulin,et al.  Enhanced secretion of TIMP-1 by human hypertrophic scar keratinocytes could contribute to fibrosis. , 2012, Burns : journal of the International Society for Burn Injuries.

[18]  F. Unglaub,et al.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids. , 2010, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[19]  L. March,et al.  Differential regulation of matrix metalloproteinase 2 and matrix metalloproteinase 9 by activated protein C: relevance to inflammation in rheumatoid arthritis. , 2007, Arthritis and rheumatism.

[20]  G. Davis,et al.  Molecular balance of capillary tube formation versus regression in wound repair: role of matrix metalloproteinases and their inhibitors. , 2006, The journal of investigative dermatology. Symposium proceedings.

[21]  Gillian Murphy,et al.  Structure and function of matrix metalloproteinases and TIMPs. , 2006, Cardiovascular research.

[22]  G. Davis,et al.  MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices , 2005, Journal of Cell Science.

[23]  S. Jeng,et al.  Flashlamp pulsed dye laser (PDL) suppression of keloid proliferation through down‐regulation of TGF‐β1 expression and extracellular matrix expression , 2004, Lasers in surgery and medicine.